The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
Adverse events associated with medium- and long-term use of opioids for chronic non-cancer pain: an overview of Cochrane Reviews
Open accessAbstract
BACKGROUND: Chronic pain is common and can be challenging to manage. Despite increased utilisation of opioids, the safety and efficacy of long-term use of these compounds for chronic non-cancer pain (CNCP) remains controversial. This overview of Cochrane Reviews complements the overview entitled 'High-dose opioids for chronic non-cancer pain: an overview of Cochrane Reviews'. OBJECTIVES: To provide an overview of the occurrence and nature of adverse events associated with any opioid agent (any dose, frequency, or route of administration) used on a medium- or long-term basis for the treatment of CNCP in adults. METHODS: We searched the Cochrane Database of Systematic Reviews (the Cochrane Library) Issue 3, 2017 on 8 March 2017 to identify all Cochrane Reviews of studies of medium- or long-term opioid use (2 weeks or more) for CNCP in adults aged 18 and over. We assessed the quality of the reviews using the AMSTAR criteria (Assessing the Methodological Quality of Systematic Reviews) as adapted for Cochrane Overviews. We assessed the quality of the evidence for the outcomes using the GRADE framework. MAIN RESULTS: We included a total of 16 reviews in our overview, of which 14 presented unique quantitative data. These 14 Cochrane Reviews investigated 14 different opioid agents that were administered for time periods of two weeks or longer. The longest study was 13 months in duration, with most in the 6- to 16-week range. The quality of the included reviews was high using AMSTAR criteria, with 11 reviews meeting all 10 criteria, and 5 of the reviews meeting 9 out of 10, not scoring a point for either duplicate study selection and data extraction, or searching for articles irrespective of language and publication type. The quality of the evidence for the generic adverse event outcomes according to GRADE ranged from very low to moderate, with risk of bias and imprecision being identified for the following generic adverse event outcomes: any adverse event, any serious adverse event, and withdrawals due to adverse events. A GRADE assessment of the quality of the evidence for specific adverse events led to a downgrading to very low- to moderate-quality evidence due to risk of bias, indirectness, and imprecision.We calculated the equivalent milligrams of morphine per 24 hours for each opioid studied (buprenorphine, codeine, dextropropoxyphene, dihydrocodeine, fentanyl, hydromorphone, levorphanol, methadone, morphine, oxycodone, oxymorphone, tapentadol, tilidine, and tramadol). In the 14 Cochrane Reviews providing unique quantitative data, there were 61 studies with a total of 18,679 randomised participants; 12 of these studies had a cross-over design with two to four arms and a total of 796 participants. Based on the 14 selected Cochrane Reviews, there was a significantly increased risk of experiencing any adverse event with opioids compared to placebo (risk ratio (RR) 1.42, 95% confidence interval (CI) 1.22 to 1.66) as well as with opioids compared to a non-opioid active pharmacological comparator, with a similar risk ratio (RR 1.21, 95% CI 1.10 to 1.33). There was also a significantly increased risk of experiencing a serious adverse event with opioids compared to placebo (RR 2.75, 95% CI 2.06 to 3.67). Furthermore, we found significantly increased risk ratios with opioids compared to placebo for a number of specific adverse events: constipation, dizziness, drowsiness, fatigue, hot flushes, increased sweating, nausea, pruritus, and vomiting.There was no data on any of the following prespecified adverse events of interest in any of the included reviews in this overview of Cochrane Reviews: addiction, cognitive dysfunction, depressive symptoms or mood disturbances, hypogonadism or other endocrine dysfunction, respiratory depression, sexual dysfunction, and sleep apnoea or sleep-disordered breathing. We found no data for adverse events analysed by sex or ethnicity. AUTHORS' CONCLUSIONS: A number of adverse events, including serious adverse events, are associated with the medium- and long-term use of opioids for CNCP. The absolute event rate for any adverse event with opioids in trials using a placebo as comparison was 78%, with an absolute event rate of 7.5% for any serious adverse event. Based on the adverse events identified, clinically relevant benefit would need to be clearly demonstrated before long-term use could be considered in people with CNCP in clinical practice. A number of adverse events that we would have expected to occur with opioid use were not reported in the included Cochrane Reviews. Going forward, we recommend more rigorous identification and reporting of all adverse events in randomised controlled trials and systematic reviews on opioid therapy. The absence of data for many adverse events represents a serious limitation of the evidence on opioids. We also recommend extending study follow-up, as a latency of onset may exist for some adverse events.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1. The Cochrane Collaboration
Higgins, J. P. T., Green, S. R., & Higgins, J. P. T. (2008) · Cited by 7,175
CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
Dowell, D., Haegerich, T. M., & Chou, R. (2016) · JAMA · doi:10.1001/jama.2016.1464 · Cited by 5,161
Development of AMSTAR: A measurement tool to assess the methodological quality of systematic reviews
Shea, B. J., Grimshaw, J. M., Wells, G. A., Boers, M., Andersson, N., Hamel, C., Porter, A. C., Tugwell, P., Moher, D., & Bouter, L. M. (2007) · BMC Medical Research Methodology · doi:10.1186/1471-2288-7-10 · Cited by 4,374
Classification of chronic pain
Merskey, H. (1994) · Medical Entomology and Zoology · Cited by 3,044
Breivik, H., Borchgrevink, P. C., Allen, S. M., Rosseland, L. A., Romundstad, L., Breivik Hals, E. K., Kvarstein, G., & Stubhaug, A. (2008) · British Journal of Anaesthesia · doi:10.1093/bja/aen103 · Cited by 2,108
The number needed to treat: a clinically useful measure of treatment effect
Cook, R. J., & Sackett, D. L. (1995) · BMJ · doi:10.1136/bmj.310.6977.452 · Cited by 1,885
Opioid Prescriptions for Chronic Pain and Overdose: A Cohort Study
Dunn, K. M., Saunders, K. W., Rutter, C. M., Banta-Green, C. J., Merrill, J. O., Sullivan, M. D., Weisner, C. M., Silverberg, M. J., Campbell, C. I., Psaty, B. M., et al. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-2-201001190-00006 · Cited by 1,255
Opioid Epidemic in the United States
Manchikanti, L. (2012) · Pain Physician · doi:10.36076/ppj.2012/15/es9 · Cited by 1,180
Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis
Vowles, K. E., McEntee, M. L., Julnes, P. S., Frohe, T., Ney, J. P., & van der Goes, D. N. (2015) · Pain · doi:10.1097/01.j.pain.0000460357.01998.f1 · Cited by 1,154
Addiction Rare in Patients Treated with Narcotics
(1980) · New England Journal of Medicine · doi:10.1056/nejm198001103020221 · Cited by 1,106
Chronic use of opioid analgesics in non-malignant pain: Report of 38 cases
Portenoy, R. K., & Foley, K. M. (1986) · Pain · doi:10.1016/0304-3959(86)90091-6 · Cited by 897
Long-term opioid management for chronic noncancer pain
Noble, M., Treadwell, J. R., Tregear, S. J., Coates, V. H., Wiffen, P. J., Akafomo, C., Schoelles, K. M., & Chou, R. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006605.pub2 · Cited by 735
Guideline for opioid therapy and chronic noncancer pain
Busse, J. W., Craigie, S., Juurlink, D. N., Buckley, D. N., Wang, L., Couban, R. J., Agoritsas, T., Akl, E. A., Carrasco-Labra, A., Cooper, L., et al. (2017) · Canadian Medical Association Journal · doi:10.1503/cmaj.170363 · Cited by 707
Opioid Dose and Drug-Related Mortality in Patients With Nonmalignant Pain
Gomes, T., Mamdani, M. M., Dhalla, I. A., Paterson, J. M., & Juurlink, D. N. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.117 · Cited by 638
The effects of opioids and opioid analogs on animal and human endocrine systems
Vuong, C., Van Uum, S. H. M., O'Dell, L. E., Lutfy, K., & Friedman, T. C. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0009 · Cited by 564
The neurobiology of opioid dependence: implications for treatment
Kosten, T., & George, T. (2002) · Science & Practice Perspectives · doi:10.1151/spp021113 · Cited by 505
Controlled-release oxycodone for pain in diabetic neuropathy: A randomized controlled trial
Gimbel, J. S., Richards, P., & Portenoy, R. K. (2003) · Neurology · doi:10.1212/01.wnl.0000057720.36503.2c · Cited by 469
McNicol, E. D., Midbari, A., & Eisenberg, E. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006146.pub2 · Cited by 434
Is the WHO analgesic ladder still valid? Twenty-four years of experience.
Vargas-Schaffer, G. (2010) · PubMed · Cited by 428
Chronic opioid use is a risk factor for the development of central sleep apnea and ataxic breathing
Walker, J. M., Farney, R. J., Rhondeau, S. M., Boyle, K. M., Valentine, K., Cloward, T. V., & Shilling, K. C. (2007) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.26908 · Cited by 419
Part III Pain Terms, A Current List with Definitions and Notes on usage
Merskey, H. (1994) · Medical Entomology and Zoology · Cited by 413
Non-steroidal anti-inflammatory drugs for chronic low back pain
Enthoven, W. T., Roelofs, P. D., Deyo, R. A., van Tulder, M. W., & Koes, B. W. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012087 · Cited by 399
ASIPP, A. (2012) · Pain Physician · doi:10.36076/ppj.2012/15/s67 · Cited by 386
Moore, R. A., & McQuay, H. J. (2005) · Arthritis Research & Therapy · doi:10.1186/ar1782 · Cited by 377
Andrew, R., Derry, S., Taylor, R. S., Straube, S., & Phillips, C. J. (2014) · Pain Practice · doi:10.1111/papr.12050 · Cited by 375
Self-citationBoscarino, J. A., Rukstalis, M., Hoffman, S. N., Han, J. J., Erlich, P. M., Gerhard, G. S., & Stewart, W. F. (2010) · Addiction · doi:10.1111/j.1360-0443.2010.03052.x · Cited by 371
“Evidence” in chronic pain–establishing best practice in the reporting of systematic reviews
Moore, A. R., Eccleston, C., Derry, S., Wiffen, P., Bell, R. F., Straube, S., & McQuay, H. (2010) · Pain · doi:10.1016/j.pain.2010.05.011 · Cited by 370
Self-citationLong-term oral opioid therapy in patients with chronic nonmalignant pain
Zenz, M., Strumpf, M., & Tryba, M. (1992) · Journal of Pain and Symptom Management · doi:10.1016/0885-3924(92)90116-y · Cited by 357
Opioid Prescribing: A Systematic Review and Critical Appraisal of Guidelines for Chronic Pain
Nuckols, T. K., Anderson, L., Popescu, I., Diamant, A. L., Doyle, B., Di Capua, P., & Chou, R. (2014) · Annals of Internal Medicine · doi:10.7326/0003-4819-160-1-201401070-00732 · Cited by 348
Oral or transdermal opioids for osteoarthritis of the knee or hip
da Costa, B. R., Nüesch, E., Kasteler, R., Husni, E., Welch, V., Rutjes, A. W., & Jüni, P. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003115.pub4 · Cited by 347
Development, feasibility and performance of a health risk appraisal questionnaire for older persons
Stuck, A. E., Kharicha, K., Dapp, U., Anders, J., von Renteln-Kruse, W., Meier-Baumgartner, H. P., Harari, D., Swift, C. G., Ivanova, K., Egger, M., et al. (2007) · BMC Medical Research Methodology · doi:10.1186/1471-2288-7-1 · Cited by 324
McCance‐Katz, E. F., Sullivan, L. E., & Nallani, S. (2010) · The American Journal on Addictions · doi:10.1111/j.1521-0391.2009.00005.x · Cited by 318
Combination pharmacotherapy for the treatment of neuropathic pain in adults
Chaparro, L. E., Wiffen, P. J., Moore, R. A., & Gilron, I. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008943.pub2 · Cited by 310
Amitriptyline for neuropathic pain in adults
Moore, R. A., Derry, S., Aldington, D., Cole, P., & Wiffen, P. J. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008242.pub3 · Cited by 286
Pharmacologic interventions for treating phantom limb pain
Alviar, M. J. M., Hale, T., & Lim-Dungca, M. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006380.pub3 · Cited by 279
Substance Use Disorders in a Primary Care Sample Receiving Daily Opioid Therapy
Fleming, M. F., Balousek, S. L., Klessig, C. L., Mundt, M. P., & Brown, D. D. (2007) · The Journal of Pain · doi:10.1016/j.jpain.2007.02.432 · Cited by 274
Opioids for chronic noncancer pain: A position paper of the American Academy of Neurology
Franklin, G. M. (2014) · Neurology · doi:10.1212/wnl.0000000000000839 · Cited by 270
Duehmke, R. M., Hollingshead, J., & Cornblath, D. R. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003726.pub3 · Cited by 267
Opioids compared to placebo or other treatments for chronic low-back pain
Chaparro, L. E., Furlan, A. D., Deshpande, A., Mailis-Gagnon, A., Atlas, S., & Turk, D. C. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004959.pub4 · Cited by 265
The ASAM principles of addiction medicine
Ries, R. K., Fiellin, D. A., Miller, S. C., & Saitz, R. (2014) · Wolters Kluwer Health eBooks · Cited by 262
Manchikanti, L., Abdi, S., Atluri, S. L., Balog, C. C., Benyamin, R. M., Boswell, M. V., Brown, K. R., Bruel, B. M., Bryce, D. A., Burks, P. A., et al. (2012) · PubMed · Cited by 243
Changes in trends and pattern of strong opioid prescribing in primary care
Zin, C. S., Chen, L. ‐., & Knaggs, R. D. (2014) · European Journal of Pain · doi:10.1002/j.1532-2149.2014.496.x · Cited by 241
Systemic administration of local anesthetic agents to relieve neuropathic pain
Challapalli, V., Tremont-Lukats, I. W., McNicol, E. D., Lau, J., & Carr, D. B. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003345.pub2 · Cited by 240
Afilalo, M., Etropolski, M. S., Kuperwasser, B., Kelly, K., Okamoto, A., Van Hove, I., Steup, A., Lange, B., Rauschkolb, C., & Haeussler, J. (2010) · Clinical Drug Investigation · doi:10.2165/11533440-000000000-00000 · Cited by 228
Spinal manipulative therapy for chronic low-back pain
Rubinstein, S. M., van Middelkoop, M., Assendelft, W. J., de Boer, M. R., & van Tulder, M. W. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008112.pub2 · Cited by 227
April, K. T., Bisaillon, J., Welch, V., Maxwell, L. J., Jüni, P., Rutjes, A., Husni, M., Vincent, J., Hindi, T. E., Wells, G., et al. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005522.pub2 · Cited by 223
Kidner, C. L., Mayer, T. G., & Gatchel, R. J. (2009) · The Journal of Bone and Joint Surgery-American Volume · doi:10.2106/jbjs.h.00286 · Cited by 208
A 1980 Letter on the Risk of Opioid Addiction
Leung, P. T. M., Macdonald, E. M., Stanbrook, M. B., Dhalla, I. A., & Juurlink, D. N. (2017) · New England Journal of Medicine · doi:10.1056/nejmc1700150 · Cited by 193
Opioids for chronic noncancer pain: A position paper of the American Academy of Neurology
Katz, J. A. (2015) · Neurology · doi:10.1212/wnl.0000000000001485 · Cited by 186
Pharmacological interventions for pain in patients with temporomandibular disorders
Mujakperuo, H. R., Watson, M., Morrison, R., & Macfarlane, T. V. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004715.pub2 · Cited by 180
Spinal manipulative therapy for acute low-back pain
Rubinstein, S. M., Terwee, C. B., Assendelft, W. J., de Boer, M. R., & van Tulder, M. W. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008880.pub2 · Cited by 179
Chapman, C. R., Lipschitz, D. L., Angst, M. S., Chou, R., Denisco, R. C., Donaldson, G. W., Fine, P. G., Foley, K. M., Gallagher, R. M., Gilson, A. M., et al. (2010) · The Journal of Pain · doi:10.1016/j.jpain.2010.02.019 · Cited by 172
Risk of Death From Accidental Overdose Associated With Psychiatric and Substance Use Disorders
Bohnert, A. S. B., Ilgen, M. A., Ignacio, R. V., McCarthy, J. F., Valenstein, M. M., & Blow, F. C. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.10101476 · Cited by 161
Interventions for the reduction of prescribed opioid use in chronic non-cancer pain
Eccleston, C., Fisher, E., Thomas, K. H., Hearn, L., Derry, S., Stannard, C., Knaggs, R., & Moore, R. A. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010323.pub3 · Cited by 159
Oxycodone for neuropathic pain in adults
Gaskell, H., Derry, S., Stannard, C., & Moore, R. A. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010692.pub3 · Cited by 153
Opioid use behaviors, mental health and pain—Development of a typology of chronic pain patients
Banta‐Green, C. J., Merrill, J. O., Doyle, S. R., Boudreau, D. M., & Calsyn, D. A. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.03.021 · Cited by 142
Nortriptyline for neuropathic pain in adults
Derry, S., Wiffen, P. J., Aldington, D. J., & Moore, R. A. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011209.pub2 · Cited by 137
Trends in high-dose opioid prescribing in Canada.
Gomes, T., Mamdani, M., Paterson, J. M., Dhalla, I. A., & Juurlink, D. N. (2014) · PubMed Central · Cited by 130
Opioid therapy for treating rheumatoid arthritis pain
Whittle, S., Richards, B. L., Husni, M. E., & Buchbinder, R. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003113.pub3 · Cited by 130
Examination of opioid prescribing in Australia from 1992 to 2007
Leong, M., Murnion, B. P., & Haber, P. (2009) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2009.01982.x · Cited by 121
Reinforcement processes in opiate addiction: A homeostatic model
Schulteis, G., & Koob, G. F. (1996) · Neurochemical Research · doi:10.1007/bf02532385 · Cited by 121
Antipsychotics for acute and chronic pain in adults
Seidel, S., Aigner, M., Ossege, M. A., Pernicka, E., Wildner, B., & Sycha, T. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004844.pub3 · Cited by 120
Long-Term Opioid Use in Non-Cancer Pain
Häuser, W., Bock, F., Engeser, P., Tölle, T. R., Willweber-Strumpf, A., & Petzke, F. W. (2014) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2014.0732 · Cited by 101
Topical Review on the Abuse and Misuse Potential of Tramadol and Tilidine in Germany
Radbruch, L., Glaeske, G., Grond, S., Münchberg, F., Scherbaum, N., Storz, E., Tholen, K., Zagermann-Muncke, P., Zieglgänsberger, W., Hoffmann-Menzel, H., et al. (2012) · Substance Abuse · doi:10.1080/08897077.2012.735216 · Cited by 100
Pharmacologic interventions for treating phantom limb pain
Alviar, M. J. M., Hale, T., & Dungca, M. L. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006380.pub2 · Cited by 100
Tapentadol for chronic musculoskeletal pain in adults
dos Santos, J. P., Alarcão, J., Fareleira, F., Carneiro, A. V., & Costa, J. N. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009923.pub2 · Cited by 92
ACOEM Practice Guidelines: Opioids for Treatment of Acute, Subacute, Chronic, and Postoperative Pain
Hegmann, K. T., Weiss, M., Bowden, K., Branco, F., DuBrueler, K., Els, C., Mandel, S., McKinney, D. W., Miguel, R. V., Mueller, K. L., et al. (2014) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0000000000000352 · Cited by 92
Self-citationHigh-dose opioids for chronic non-cancer pain: an overview of Cochrane Reviews
Els, C., Jackson, T., Hagtvedt, R., Kunyk, D., Sonnenberg, B., Lappi, V. G., & Straube, S. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012299.pub2 · Cited by 84
Self-citationOxycodone for neuropathic pain and fibromyalgia in adults
Gaskell, H., Moore, R. A., Derry, S., & Stannard, C. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010692.pub2 · Cited by 82
O'Donnell, J., Ekman, E., Spalding, W., Bhadra, P., McCabe, D., & Berger, M. F. (2009) · Journal of International Medical Research · doi:10.1177/147323000903700615 · Cited by 81
Ramiro, S., Radner, H., van der Heijde, D. M. F. M., van Tubergen, A. M., Buchbinder, R., Aletaha, D., & Landewé, R. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008886.pub2 · Cited by 80
Moore, A., Derry, S., Aldington, D. J., & Wiffen, P. J. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011407.pub2 · Cited by 78
Evidence for analgesic effect in acute pain – 50 years on
McQuay, H. J., Derry, S., Eccleston, C., Wiffen, P. J., & Moore, A. R. (2012) · Pain · doi:10.1016/j.pain.2012.01.024 · Cited by 66
Relationship of Chronic Pain and Opioid Use with Respiratory Disturbance during Sleep
Jungquist, C. R., Flannery, M. A., Perlis, M. L., & Grace, J. T. (2010) · Pain Management Nursing · doi:10.1016/j.pmn.2010.04.003 · Cited by 64
Methadone for chronic non-cancer pain in adults
Haroutounian, S., McNicol, E. D., & Lipman, A. G. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008025.pub2 · Cited by 60
Opioids, Sleep, and Sleep-Disordered Breathing
Zutler, M., & Holty, J.-E. C. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211796197070 · Cited by 52
Hydromorphone for neuropathic pain in adults
Stannard, C., Gaskell, H., Derry, S., Aldington, D. J., Cole, P., Cooper, T. E., Knaggs, R., Wiffen, P. J., & Moore, R. A. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011604.pub2 · Cited by 51
Fentanyl for neuropathic pain in adults
Derry, S., Stannard, C., Cole, P., Wiffen, P. J., Knaggs, R., Aldington, D. J., & Moore, R. A. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011605.pub2 · Cited by 51
Overdose and prescribed opioids: Associations among chronic non-cancer pain patients
Dunn, K. M., Saunders, K. W., Rutter, C. M., Banta‐Green, C. J., Merrill, J. O., Sullivan, M. D., Weisner, C. M., Silverberg, M. J., Campbell, C. I., Psaty, B. M., et al. (2010) · PubMed Central · doi:10.1059/0003-4819-152-2-201001190-00006 · Cited by 44
Interventions for the reduction of prescribed opioid use in chronic non-cancer pain
Windmill, J., Fisher, E., Eccleston, C., Derry, S., Stannard, C., Knaggs, R., & Moore, A. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010323.pub2 · Cited by 41
ACOEM Practice Guidelines: Opioids and Safety-Sensitive Work
Hegmann, K. T., Weiss, M., Bowden, K., Branco, F., DuBrueler, K., Els, C., Mandel, S., McKinney, D. W., Miguel, R. V., Mueller, K. L., et al. (2014) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0000000000000237 · Cited by 39
Self-citationNonopioid Substance Use Disorders and Opioid Dose Predict Therapeutic Opioid Addiction
Huffman, K. L., Shella, E., Sweis, G. W., Griffith, S. D., Scheman, J., & Covington, E. C. (2014) · Journal of Pain · doi:10.1016/j.jpain.2014.10.011 · Cited by 38
Shafer, S. L., & Flood, P. D. (2008) · Springer eBooks · doi:10.1007/978-0-387-72527-7_15 · Cited by 29
Hagen, N. A., Flynne, P., Hays, H., & Macdonald, N. (1995) · PubMed Central · Cited by 26
High-dose opioids for chronic non-cancer pain: an overview of Cochrane reviews
Els, C., Hagtvedt, R., Kunyk, D., Sonnenberg, B., Lappi, V. G., & Straube, S. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012299 · Cited by 22
Self-citation
Cited by
Stockings, E., Campbell, G., Hall, W. D., Nielsen, S., Zagic, D., Rahman, R., Murnion, B., Farrell, M., Weier, M., & Degenhardt, L. (2018) · Pain · doi:10.1097/j.pain.0000000000001293 · Cited by 460
Sinclair, J., Smith, C. A., Abbott, J., Chalmers, K. J., Pate, D. W., & Armour, M. (2020) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2019.08.033 · Cited by 65
Esteve, R., Marcos, E., Reyes-Pérez, Á., López-Martínez, A. E., & Ramírez-Maestre, C. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18063054 · Cited by 17
Ellerbroek, H., Hanssen, I., Lathouwers, K., Cillessen, L., Dekkers, S., Veldman, S. E., van den Heuvel, S. A. S., Speckens, A. E. M., & Schellekens, A. F. A. (2023) · Brain and Behavior · doi:10.1002/brb3.3005 · Cited by 5
“MBIs have repeatedly been shown effective in improving coping with negative emotions, both in patients with mood and anxiety disorders (Goldberg et al., 2018) and in patients with chronic pain (Chiesa & Serretti, 2011; Esmer et al., 2010; Garland et al., 2012, 2014).”
Metadata
- Authors
- Els, C., Jackson, T. D., Kunyk, D., Lappi, V. G., Sonnenberg, B., Hagtvedt, R., Sharma, S., Kolahdooz, F., & Straube, S.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2017-10-30
- Volume
- 2018
- Issue
- 1
- Pages
- CD012509-CD012509
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W2577281584
- Cited by
- 284
- References
- 86
- FWCI
- 20.27
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.